70461-025Level 3
FLUAD (INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED))
**Product type:** Vaccine
**Active ingredient:** INFLUENZA A VIRUS A/CROATIA/10136RV/2023 X-425A (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA A VIRUS A/VICTORIA/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED); INFLUENZA B VIRUS B/AUSTRIA/1359417/2021 BVR-26 ANTIGEN (FORMALDEHYDE INACTIVATED)
**Strength:** 15; 15; 15 ug/.5mL; ug/.5mL; ug/.5mL
**Dosage form:** Injection, Suspension
**Route:** Intramuscular
**Labeler:** Seqirus, Inc.
**Marketing category:** BLA (BLA125510)
GET
/api/v1/systems/ndc_fda/nodes/70461-025Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.